Design, Synthesis, and Biological Evaluation of Novel Quinazoline Clubbed Thiazoline Derivatives.

about

Design, Synthesis, and Biological Evaluation of Novel Quinazoline Clubbed Thiazoline Derivatives.

Item

http://www.wikidata.org/entity/Q53571737

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Design, Synthesis, and Biologi ...... lubbed Thiazoline Derivatives.

@en

Design, Synthesis, and Biologi ...... lubbed Thiazoline Derivatives.

@nl

type

Item

label

Design, Synthesis, and Biologi ...... lubbed Thiazoline Derivatives.

@en

Design, Synthesis, and Biologi ...... lubbed Thiazoline Derivatives.

@nl

prefLabel

Design, Synthesis, and Biologi ...... lubbed Thiazoline Derivatives.

@en

Design, Synthesis, and Biologi ...... lubbed Thiazoline Derivatives.

@nl

P1476

Design, Synthesis, and Biologi ...... lubbed Thiazoline Derivatives.

@en

P2093

Ahsan A Khan

http://www.w3.org/2001/XMLSchema#string

Anees A Siddiqui

http://www.w3.org/2001/XMLSchema#string

Md J Akhtar

http://www.w3.org/2001/XMLSchema#string

Md R Haider

http://www.w3.org/2001/XMLSchema#string

Mohammad S Yar

http://www.w3.org/2001/XMLSchema#string

Zulphikar Ali

http://www.w3.org/2001/XMLSchema#string

P2860

Discovery of alogliptin: a potent, selective, bioavailable, and efficacious inhibitor of dipeptidyl peptidase IV

Design and synthesis of pyrimidinone and pyrimidinedione inhibitors of dipeptidyl peptidase IV

Structure-based design of pyridopyrimidinediones as dipeptidyl peptidase IV inhibitors

Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.

Discovery of Imigliptin, a Novel Selective DPP-4 Inhibitor for the Treatment of Type 2 Diabetes.

Clinical pharmacokinetics and pharmacodynamics of linagliptin.

Medicinal chemistry approaches to the inhibition of dipeptidyl peptidase-4 for the treatment of type 2 diabetes.

Structure based lead optimization approach in discovery of selective DPP4 inhibitors.

Discovery and structure-activity relationships of a novel class of quinazoline glucokinase activators.

Synthesis and biological evaluation of xanthine derivatives on dipeptidyl peptidase 4.

P31

scholarly article

P356

10.1002/ARDP.201600298

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

350

http://www.w3.org/2001/XMLSchema#string

P577

2017-01-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28093794

http://www.w3.org/2001/XMLSchema#string